Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.
Isoniazid (INH) is part of the first-line-therapy for tuberculosis (TB) but can cause drug-induced liver injury (DILI). Several candidate single nucleotide polymorphisms (SNPs) have been previously identified but the clinical utility of these SNPs in the prediction of INH-DILI remains uncertain. The...
Main Authors: | Sze Ling Chan, Angeline Poh Gek Chua, Folefac Aminkeng, Cynthia Bin Eng Chee, Shengnan Jin, Marie Loh, Suay Hong Gan, Yee Tang Wang, Liam R Brunham |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5642896?pdf=render |
Similar Items
-
NAT2 Genotype and Isoniazid Medication in Children
by: Klaus Golka, et al.
Published: (2016-09-01) -
Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients
by: Dr. A. Toure, et al.
Published: (2016-01-01) -
NAT2 gene polymorphisms and plasma isoniazid concentration in Vietnamese tuberculosis patients
by: Anh Tuan Le, et al.
Published: (2019-11-01) -
The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
by: Usanee Ungcharoen, et al.
Published: (2020-12-01) -
Chronic dialysis, NAT2 polymorphisms, and the risk of isoniazid-induced encephalopathy – case report and literature review
by: Stefan Matei Constantinescu, et al.
Published: (2017-09-01)